| | Other Issues: previous | next | latest | archiveOriginal Research The effects of rivastigmine plus selegiline on brain acetylcholinesterase, (Na+, K+)-, Mg2+-ATPase activities, antioxidant status, and learning performance of aged rats Haris Carageorgiou, Antonios C Sideris, Ioanna Messari, Chrissoula I Liakou, and Stylianos Tsakiris PMCID: PMC2536534 A preliminary report of the dopamine receptor D4 and the dopamine transporter 1 gene polymorphism and its association with attention deficit hyperactivity disorder Helmut Niederhofer, Frauke Menzel, Karl Göbel, Brigitte Hackenberg, Rainer Richter, Maria Hildegard Walter, Christian Gross, Markus Huber, Roger Pycha, and Hans-Jürgen Menzel PMCID: PMC2536535 Beneficial effect of pramipexole for motor function and depression in Parkinson’s disease Osamu Kano, Ken Ikeda, Tetsuhito Kiyozuka, Konosuke Iwamoto, Hirono Ito, Yuji Kawase, Ryuta Sato, Toshiki Fujioka, Yo Araki, Shigeji Baba, and Yasuo Iwasaki PMCID: PMC2536536 Parkinson’s disease and the frequent reasons for emergency admission Ozlem Guneysel, Oguzhan Onultan, and Ozge Onur PMCID: PMC2536537 Cognitive impairment and Alzheimer’s disease: Links with oxidative stress and cholesterol metabolism Alejandra Sekler, José M Jiménez, Leonel Rojo, Edgard Pastene, Patricio Fuentes, Andrea Slachevsky, and Ricardo B Maccioni PMCID: PMC2536538 Expert Opinion Risperidone in the treatment of behavioral disorders associated with autism in children and adolescents Roberto Canitano and Valeria Scandurra PMCID: PMC2536539 Tiagabine: efficacy and safety in partial seizures – current status Jürgen Bauer and Déirdre Cooper-Mahkorn PMCID: PMC2536540 Reviews Diffusion tensor imaging investigations in Alzheimer’s disease: the resurgence of white matter compromise in the cortical dysfunction of the aging brain David A Medina and Moises Gaviria PMCID: PMC2536541 Current approaches to the treatment of Parkinson’s disease Joseph Jankovic and L Giselle Aguilar PMCID: PMC2536542 Anxiolytics may promote locomotor function recovery in spinal cord injury patients Pierre A Guertin PMCID: PMC2536543 Present and prospective clinical therapeutic regimens for Alzheimer’s disease Mustafa M Husain, Kenneth Trevino, Haroon Siddique, and Shawn M McClintock PMCID: PMC2536544 Pharmacotherapy of panic disorder Charles B Pull and Cristian Damsa PMCID: PMC2536545 Psychiatric disorders and traumatic brain injury Marcelo Schwarzbold, Alexandre Diaz, Evandro Tostes Martins, Armanda Rufino, Lúcia Nazareth Amante, Maria Emília Thais, João Quevedo, Alexandre Hohl, Marcelo Neves Linhares, and Roger Walz PMCID: PMC2536546 Estrogen receptor-mediated neuroprotection: The role of the Alzheimer’s disease-related gene seladin-1 Alessandro Peri and Mario Serio PMCID: PMC2536547 Case Report Very early onset and greater vulnerability in schizophrenia: A clinical and neuroimaging study Francesco Margari, Anna Presicci, Maria Giuseppina Petruzzelli, Patrizia Ventura, Franca Di Cuonzo, Michele Palma, and Lucia Margari PMCID: PMC2536548 |
